E. Liébana
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
- Endocrinology top 0.2%
- Vibrio bacteria research studies
Papers in
-
- Antibiotic Resistance in Bacteria 25
-
- Vibrio bacteria research studies 10
- Escherichia coli research studies 9
- Co-authors
- Alicia AranazMiranda BatchelorKatie L. HopkinsAna MateosLucas Domı́nguezRobert DaviesDebby CousinsMartin J. Woodward
- Journals
- Journal of Clinical Microbiology (19 papers)Veterinary Microbiology (5 papers)International Journal of Food Microbiology (4 papers)Journal of Applied Microbiology (4 papers)Microbial Drug Resistance (4 papers)
- Partner nations
- United KingdomSpainItaly
In The Last Decade
E. Liébana
89 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 98
- Molecular Medicine 1.3k
- Endocrinology 1.0k
- Food Science 1.6k
- Infectious Diseases 1.6k
- Biotechnology 413
Countries citing papers authored by E. Liébana
This map shows the geographic impact of E. Liébana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Liébana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Liébana more than expected).
Fields of papers citing papers by E. Liébana
This network shows the impact of papers produced by E. Liébana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Liébana. The network helps show where E. Liébana may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Liébana, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 36 | |
| 2 | The Role of the European Food Safety Authority (EFSA) in the Fight against Antimicrobial Resistance (AMR) | 2018 | 4 |
| 3 | 2018 | 16 | |
| 4 | 2018 | 9 | |
| 5 | 2014 | 23 | |
| 6 | 2012 | 210 | |
| 7 | 2009 | 18 | |
| 8 | 2008 | 13 | |
| 9 | Antibioticumresistentie bij Escherichia coli O157 geisoleerd tussen 1998 en 2003 in Nederland | 2007 | 1 |
| 10 | 2007 | 43 | |
| 11 | 2007 | 26 | |
| 12 | 2007 | 12 | |
| 13 | 2007 | 81 | |
| 14 | 2006 | 35 | |
| 15 | 2006 | 5 | |
| 16 | 2005 | 34 | |
| 17 | 2002 | 20 | |
| 18 | 2002 | 32 | |
| 19 | 1998 | 42 | |
| 20 | 1997 | 31 |
About E. Liébana
E. Liébana is a scholar working on Molecular Medicine, Endocrinology, Food Science, Infectious Diseases and Biotechnology, having authored 90 papers that have together received 3.9k indexed citations. Recurring topics across this work include Salmonella and Campylobacter epidemiology (49 papers), Antibiotic Resistance in Bacteria (25 papers), Mycobacterium research and diagnosis (20 papers), Bacteriophages and microbial interactions (20 papers), Tuberculosis Research and Epidemiology (17 papers), Listeria monocytogenes in Food Safety (12 papers), Vibrio bacteria research studies (10 papers) and Escherichia coli research studies (9 papers). The work is most often cited by research in Molecular Medicine (1.3k citations), Endocrinology (1.0k citations), Food Science (1.6k citations), Infectious Diseases (1.6k citations) and Biotechnology (413 citations). E. Liébana has collaborated with scholars based in United Kingdom, Spain and Italy. Frequent co-authors include Alicia Aranaz, Miranda Batchelor, Katie L. Hopkins, Ana Mateos, Lucas Domı́nguez, Robert Davies, Debby Cousins, Martin J. Woodward, F.A. Clifton-Hadley and E. J. Threlfall. Their work appears in journals such as Journal of Clinical Microbiology, Veterinary Microbiology, International Journal of Food Microbiology, Journal of Applied Microbiology and Microbial Drug Resistance.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.